Explore Our Biomarker Menu

Biomarker:

IL-17B

Biological or Clinical Significance:

The protein encoded by this gene is a T cell-derived cytokine that shares sequence similarity with IL17. This cytokine was reported to stimulate the release of TNF alpha (TNF) and IL1 beta (IL1B) from a monocytic cell line. Immunohistochemical analysis of several nerve tissues indicated that this cytokine is primarily localized to neuronal cell bodies. IL-17B is expressed in several peripheral tissues and immune tissues, namely in adult pancreas, small intestine, and stomach. IL17B (Interleukin 17B) is a Protein Coding gene. Diseases associated with IL17B include leiomyoma and charcot-marie-tooth disease. Among its related pathways are TGF-Beta Pathway and Akt Signaling. GO annotations related to this gene include cytokine activity. An important paralog of this gene is IL17D.

References:

Analyte:

IL-17B

Matrix:

Status:

Experienced Running

Sensitivity-LLOQ:

Sensitivity-ULOQ:

platform

MSD-ECL

Required Sample Volume

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.


    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.